Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Measles; Mumps; Rubella | Phase 3 | ClinicalTrials |
| Meningococcal Infections | Phase 3 | ClinicalTrials |
| Malaria; Malaria, Falciparum | Phase 1 | ClinicalTrials |
| Hepatitis; Hepatitis A; Hepatitis B | Phase 4 | ClinicalTrials |
| Hepatitis; Hepatitis A | Phase 4 | ClinicalTrials |
| Measles; Rubella | Phase 3 | ClinicalTrials |
| Malaria | Phase 2 | ClinicalTrials |
| Meningococcal Infections | Phase 2 | ClinicalTrials |
| Hepatitis; Hepatitis A; Hepatitis B | Phase 4 | ClinicalTrials |
| Hepatitis; Hepatitis A; Hepatitis B | Phase 4 | ClinicalTrials |
| Streptococcal Infections | Phase 2 | ClinicalTrials |
| Hepatitis; Hepatitis A; Hepatitis B | Phase 4 | ClinicalTrials |
| Bipolar Disorder; Disease; Psychotic Disorders; Schizophrenia; Substance-Related Disorders | Phase 2 | ClinicalTrials |
| Encephalitis; Encephalitis, Japanese | Phase 3 | ClinicalTrials |
| Otitis; Otitis Media; Pneumonia; Streptococcal Infections | Phase 3 | ClinicalTrials |
| Hepatitis; Hepatitis A; Hepatitis B | Phase 2 | ClinicalTrials |
| Hepatitis; Hepatitis A; Hepatitis B | Phase 4 | ClinicalTrials |
| Measles; Mumps; Rubella | Phase 3 | ClinicalTrials |
| Acquired Immunodeficiency Syndrome; Hepatitis; Hepatitis A; Hepatitis B; HIV Infections; Infection | Phase 3 | ClinicalTrials |
| Hepatitis A | Phase 3 | ClinicalTrials |
| Diphtheria | Phase 4 | ClinicalTrials |
| Hepatitis C; Infection | Phase 1 | ClinicalTrials |
| Hepatitis; Hepatitis A; Hepatitis B | Phase 4 | ClinicalTrials |
CONTENTS